Sustanon 250 - a drug that has a distinct androgenic effect.
Structure and Composition of Sustanon 250
The oil solution for intramuscular injection yellow. Composition 1 ampoule: Testosterone propionate (30 mg), testosterone phenylpropionate (60 mg) of testosterone izokaproat (60 mg) of testosterone decanoate (100 mg) and adjuvants (benzyl alcohol, peanut oil, nitrogen).
According to the instructions, Sustanon 250 contains a blend of four testosterone esters - an endogenous hormone, necessary for the normal development of male secondary sexual characteristics and sexual organs. When injected into the blood, the esters are rapidly hydrolyzed to testosterone - a natural human hormone. Over the life of men, testosterone helps maintain his libido, potency, well-being, ensuring proper functioning of the testes, seminal vesicles, prostate, and related structures.
Treatment with Sustanon 250 leads to increased concentrations of testosterone, estradiol, dihydrotestosterone, and androstenedione in the plasma and globulin lowering sex hormone binding. Receiving means reduces the serum concentration of HDL and low-density, triglycerides, increasing the concentration of hemoglobin and hematocrit. At this level of follicle-stimulating and luteinizing hormones are restored to normal indicator.
Application Sustanon 250 leads to increased muscle mass, bone density, obese patients is a significant reduction in body weight. By all accounts, Sustanon 250 well normalizes sexual function, including libido, without causing significant changes in the level of prostate-specific antigen, and liver enzymes.
Indications for use Sustanon 250
The drug Sustanon 250 is effective as replacement therapy in the presence of the following conditions:
- Androgen deficiency after castration;
- Osteoporosis is caused by lack of androgen;
- Endocrine impotence;
- Reduced physical and mental activity, libido.
The use of Sustanon 250 is prohibited in the presence of suspected or already established breast carcinoma or prostate cancer. Treatment with undesirable in the presence of hypersensitivity to any component of the agent.
With careful treatment of Sustanon 250 is assigned to the boys for several years before puberty (to avoid premature epiphyseal closure) in chronic heart, kidney, liver failure, prostatic hypertrophy, diabetes, chronic lung disease, obesity in childhood.
Side effects Sustanon 250
According to the instructions to Sustanon 250, from sexual and endocrine systems detect side effects such as precocious puberty, excessive sexual stimulation (priapism), penis enlargement, oligospermia, premature closure of the epiphysis, water retention and sodium (swelling). On the part of the cardiovascular system, according to the reviews Sustanon 250, may increase blood pressure.
In addition to these side effects have also noted increased nervous irritability, depression, mood changes, decreased or increased libido, nausea, acne.
Dosage Sustanon 250 and overdose
The optimum dosage Sustanon 250 under the instruction is 1 ml of 3 weeks, and depends usually on individual patient response. Acute overdose with intramuscular injection does not cause extreme toxicity: Symptoms of chronic overdose as is the development of priapism in men. In the event of prolonged painful erection unrelated to sexual arousal, it is recommended to temporarily stop taking the drug, and after the disappearance of symptoms resume treatment Sustanon 250 at lower doses.
When receiving Sustanon 250 patients should be carried out medical control: every 3 months throughout the treatment period is recommended to measure hemoglobin and hematocrit, digital rectal examination.
Receiving androgens including Sustanon 250 and in the elderly, increases the risk of developing prostate cancer.
On responses to Sustanon 250, use of the drug is not prescribed by a doctor, and to increase endurance athletes, is a significant health risk.
Storage of the drug is carried out in a dark place at a temperature of 10-30 degrees Celsius. Shelf life Sustanon 250 is 5 years. Do not use medication after the expiration date.